Qijun Qian
- Oncology top 2%
- CAR-T cell therapy research 46
- Cancer Immunotherapy and Biomarkers 10
- Biotechnology top 1%
- Cancer Research and Treatments 30
- Genetics top 2%
- Virus-based gene therapy research 62
- Immunology top 5%
- Immunotherapy and Immune Responses 10
- Cancer Research top 5%
-
- Viral Infectious Diseases and Gene Expression in Insects 23
- RNA Interference and Gene Delivery 22
- CRISPR and Genetic Engineering 13
- Cited by
- OncologyBiotechnologyGenetics
- Journals
- Nucleic Acids Research (1 paper)Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Qijun Qian
122 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 1.6k
- Biotechnology 349
- Genetics 1.1k
- Immunology 710
- Cancer Research 341
Countries citing papers authored by Qijun Qian
This map shows the geographic impact of Qijun Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qijun Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qijun Qian more than expected).
Fields of papers citing papers by Qijun Qian
This network shows the impact of papers produced by Qijun Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qijun Qian. The network helps show where Qijun Qian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qijun Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 15 | |
| 3 | Overexpression of hsa_circ_0001715 is a Potential Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma | 2020 | 1 |
| 4 | 2020 | 125 | |
| 5 | Current Progress in CAR-T Cell Therapy for Solid Tumors | 2019 | 2 |
| 6 | Isolation and identification of pathogen from Hylocereus undatus cv. Zihonglong in Guizhou province. | 2018 | 1 |
| 7 | 2016 | 9 | |
| 8 | 2016 | 21 | |
| 9 | 2016 | 13 | |
| 10 | 2013 | 4 | |
| 11 | Effect of LIF on the Mouse Embryo Stem Cells under Serum-Free Condition | 2011 | 1 |
| 12 | Expression of human Oct4 and cell penetrating peptide fusion protein | 2010 | 1 |
| 13 | 2009 | 20 | |
| 14 | [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma]. | 2009 | 1 |
| 15 | An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection. | 2009 | 2 |
| 16 | Antitumor activity of replication-defective adenovirus carrying human tumor necrosis factor-related apoptosis-inducing ligand gene on human small cell lung cancer cell line H446 in vitro | 2007 | 1 |
| 17 | 2006 | 26 | |
| 18 | 2006 | 0 | |
| 19 | 2005 | 1 | |
| 20 | 1997 | 3 |
About Qijun Qian
Qijun Qian is a scholar working on Biotechnology, Oncology and Genetics, having authored 127 papers that have together received 2.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (62 papers), CAR-T cell therapy research (46 papers), Cancer Research and Treatments (30 papers), Viral Infectious Diseases and Gene Expression in Insects (23 papers), RNA Interference and Gene Delivery (22 papers), CRISPR and Genetic Engineering (13 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Oncology (1.6k citations), Biotechnology (349 citations) and Genetics (1.1k citations). Qijun Qian has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhenlong Ye, Huajun Jin, Xinyuan Liu, Zhong Li, Liang Cheng, Xinyue Wang, Xinchun Li, Changzheng Zhang, Shuo Ma and Mengchao Wu. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.